Comparing Linezolid and Vancomycin for Preventing Surgical Site Infections

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of two antibiotics, Linezolid and Vancomycin, in preventing surgical site infections (SSIs) in patients undergoing elective surgeries where beta-lactam antibiotics are not suitable. The study focuses on patients with known allergies to beta-lactams or those at risk for methicillin-resistant Staphylococcus aureus (MRSA) infections. By administering these antibiotics within 24 hours of surgery, the trial aims to determine which antibiotic is more effective in reducing the incidence of SSIs. The outcomes will be assessed by measuring SSI rates and identifying the microorganisms responsible for any infections that occur post-surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients undergoing any elective surgery for which vancomycin is recommended in the guidelines as an alternative to beta-lactams including: neurosurgery, cardiac surgery, orthopedic surgery, vascular surgery, penile and testicular surgery, gastric banding procedure in digestive surgery.

This inclusion criteria can lead to the inclusion of patients who undergo a re-intervention provided that the re-intervention is not due to a suspected or proven infection and that the patient was not included in LOVip at the time of his/her first intervention;

* Age ≥ 18 years-old;
* Known allergy to beta-lactams AND/OR suspected or proven MRSA colonization. Proven MRSA colonization is defined as a positive patient sample (any type of swab or biological fluid) for MRSA within 3 months prior to surgery. MRSA colonization is suspected when the patient undergoing surgery has received antibiotic treatment within 3 months prior to surgery or is undergoing re-intervention more than 5 days after the first surgery. MRSA is defined as a strain of Staphylococcus aureus resistant to oxacillin or cefoxitin, predicting non-susceptibility to all classes of beta-lactam antimicrobials (except anti-MRSA cephalosporins) (6). In contrast, MSSA is defined as an oxacillin sensitive strain of Staphylococcus aureus;
* Informed consent of the patient;
* Affiliated to a social security system or equivalent.

Exclusion Criteria:

* Surgery for suspected or proven SSI (definition of SSI provided on chapter 3.6.1 Primary endpoint as defined by (5, 7)) according to international definitions;
* Obesity defined by a body mass index (BMI) \> 35 kg/m2 or a body weight \> 100 kg;
* Chronic kidney disease defined as glomerular filtration rate (GFR) \< 60 ml/min per 1.73m2;
* Known allergy to linezolid or vancomycin;
* Hematologic malignancy;
* Declared pregnancy or breastfeeding;
* Patient under legal protection regime for adults;
* Patient denying consent;
* Patient already included in LOVip for a previous surgery.

Where it's running

• Anesthésie Réanimation - Hôpital Nord (AP-HM)
  Marseille, France Recruiting

Study contacts

• Study coordinator: Marc Leone, MD
• Email: Marc.LEONE@ap-hm.fr
• Phone: 0491968655

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Which single-dose antibiotic works best to prevent complications after lower wisdom tooth removal

  This trial tests whether a single dose of amoxicillin, clindamycin, or azithromycin is best at reducing post-surgery problems for adults undergoing lower wisdom tooth extraction.

  Recruiting Phase 4 Dow University of Health Sciences · Karachi, Sindh · NCT07894016

• Piperacillin Prophylaxis in Major Liver and Pancreatic Surgery

  This study tests whether piperacillin/tazobactam given around surgery reliably reaches the right levels to help prevent infections in adults undergoing major liver or pancreatic surgery.

  Recruiting Central Hospital, Nancy, France · Vandœuvre-lès-Nancy, Lorraine and 1 other locations · NCT07558681

• Antibiotic Prophylaxis Before Simple Tooth Extraction in Immunosuppressed Patients with Autoimmune Rheumatic Diseases

  This trial tests whether giving a single dose of amoxicillin before a simple tooth extraction can prevent infections in adults with autoimmune rheumatic diseases who are on immunosuppressive therapy.

  Recruiting Phase 4 University of Sao Paulo General Hospital · São Paulo, São Paulo · NCT07275580

• Adding azithromycin to ampicillin for late PPROM

  This test sees if adding a single dose of azithromycin to the usual ampicillin/amoxicillin treatment helps newborns when membranes break early between 34.0 and 36.6 weeks.

  Recruiting Phase 4 Sheba Medical Center · Ramat Gan, Israel · NCT07183462

• Cefazolin Prophylaxis and CSF Levels in Ventricular Shunt Surgery

  This study tests whether a standard 2 g dose of cefazolin given before ventricular shunt surgery yields enough drug in the brain’s fluid to help prevent valve infections.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07067736

• Understanding antibiotic resistance and microbiome changes in STI prevention

  This study is trying to see how using doxycycline for STI prevention affects antibiotic resistance and changes in gut bacteria in men who have sex with men.

  Recruiting University College, London · London · NCT06778083

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.